University of British Columbia, The Centre for Huntingtons Disease
Welcome,         Profile    Billing    Logout  
 6 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Leavitt, Blair R
HDClarity, NCT02855476: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

Recruiting
N/A
2500
Europe, Canada, US, RoW
University College, London, CHDI Foundation, Inc.
Huntington's Disease
05/25
05/25
Le, Tuan N
HPV9vxFSW, NCT06681636: Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure

Not yet recruiting
2
300
RoW
Human papillomavirus 9-valent vaccine, Recombinant, Gardasil 9
National Institute of Hygiene and Epidemiology, Vietnam, Murdoch Childrens Research Institute, CENTER FOR SUPPORTING COMMUNITY DEVELOPMENT INITIATIVES, Hai phong Center for Disease Control
HPV Infection, Cervical Cancer, Anogenital Cancer, Anogenital Warts
10/26
12/27
NALPAC, NCT05472259 / 2020-003889-39: A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC

Recruiting
2
134
Europe
Nanoliposomal irinotecan, Onyvide, 5 FU, Fluorouracil, Leucovorin, Folinate, Elvorine, Oxaliplatin
Belgian Group of Digestive Oncology, University Hospital St Luc, Brussels
Metastatic Pancreatic Ductal Adenocarcinoma
12/26
12/27
Bang, Jee
CT-AMT-130-01, NCT04120493: Safety and Proof-of-Concept (POC) Study with AMT-130 in Adults with Early Manifest Huntington's Disease

Hourglass Jan 2021 - Dec 2021 : Early efficacy data on initial patients for Huntington's disease
Checkmark First biomarker data from trial for Huntington’s disease
Nov 2021 - Nov 2021: First biomarker data from trial for Huntington’s disease
Checkmark Safety data from P1/2 trial for Huntington’s disease
Feb 2021 - Feb 2021: Safety data from P1/2 trial for Huntington’s disease
Recruiting
1/2
37
US
intra-striatal rAAV5-miHTT, AMT-130, Imitation (sham) surgery
UniQure Biopharma B.V.
Huntington's Disease
04/29
06/29
HDClarity, NCT02855476: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

Recruiting
N/A
2500
Europe, Canada, US, RoW
University College, London, CHDI Foundation, Inc.
Huntington's Disease
05/25
05/25
NCT01574053: Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Recruiting
N/A
35000
Europe, Canada, US, RoW
CHDI Foundation, Inc.
Huntington's Disease
01/62
01/62
Adurogbangba, Mike
HDClarity, NCT02855476: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

Recruiting
N/A
2500
Europe, Canada, US, RoW
University College, London, CHDI Foundation, Inc.
Huntington's Disease
05/25
05/25
NCT01574053: Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Recruiting
N/A
35000
Europe, Canada, US, RoW
CHDI Foundation, Inc.
Huntington's Disease
01/62
01/62

Download Options